205
Views
0
CrossRef citations to date
0
Altmetric
REVIEW

Natural Language Processing for Radiation Oncology: Personalizing Treatment Pathways

, , & ORCID Icon
Pages 65-76 | Received 23 Aug 2023, Accepted 29 Jan 2024, Published online: 12 Feb 2024
 

Abstract

Natural language processing (NLP), a technology that translates human language into machine-readable data, is revolutionizing numerous sectors, including cancer care. This review outlines the evolution of NLP and its potential for crafting personalized treatment pathways for cancer patients. Leveraging NLP’s ability to transform unstructured medical data into structured learnable formats, researchers can tap into the potential of big data for clinical and research applications. Significant advancements in NLP have spurred interest in developing tools that automate information extraction from clinical text, potentially transforming medical research and clinical practices in radiation oncology. Applications discussed include symptom and toxicity monitoring, identification of social determinants of health, improving patient-physician communication, patient education, and predictive modeling. However, several challenges impede the full realization of NLP’s benefits, such as privacy and security concerns, biases in NLP models, and the interpretability and generalizability of these models. Overcoming these challenges necessitates a collaborative effort between computer scientists and the radiation oncology community. This paper serves as a comprehensive guide to understanding the intricacies of NLP algorithms, their performance assessment, past research contributions, and the future of NLP in radiation oncology research and clinics.

Disclosure

JH: Research Funding from American Cancer Society, American Society for Clinical Oncology/Conquer Cancer Foundation, American Society for Radiation Oncology, National Institutes of Health/National Cancer Institute, Prostate Cancer Foundation, Radiation Oncology Institute, Roche. HL: Research Funding from DOD, Uncle Kory Foundation. The authors report no other conflicts of interest in this work.